Dark
Light
System
Institutional Investment Manager
ORBIMED ADVISORS LLC
ORBIMED ADVISORS LLC (CIK: 0001055951) incorporated in Delaware, located at 601 Lexington Avenue, New York, NY. Institutional holdings reported to the SEC.

Institutional Holdings (2016Q1)
Portfolio Summary: 141 holdings with a total value of $9,503,629,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 BRISTOL MYERS SQUIBB CO 7,624,900 487,079,000 5.13%
2 HCA HOLDINGS INC 5,737,100 447,781,000 4.71%
3 AMGEN INC 2,876,000 431,199,000 4.54%
4 BOSTON SCIENTIFIC CORP 22,479,700 422,843,000 4.45%
5 ABBVIE INC 7,395,700 422,442,000 4.45%
6 ALLERGAN PLC 1,572,715 421,535,000 4.44%
7 BIOGEN INC 1,526,300 397,326,000 4.18%
8 CELGENE CORP 3,774,077 377,747,000 3.97%
9 GILEAD SCIENCES INC 3,019,200 277,344,000 2.92%
10 ALEXION PHARMACEUTIC 1,870,600 260,425,000 2.74%
11 IMPAX LABORATORIES INC 6,776,100 216,971,000 2.28%
12 THERMO FISHER SCIENTIFIC INC 1,435,000 203,182,000 2.14%
13 INCYTE 2,755,078 199,661,000 2.10%
14 REGENERON PHARMACEUTICALS 533,000 192,115,000 2.02%
15 LILLY ELI & CO 2,541,300 182,999,000 1.93%
16 WELLCARE HEALTH PLANS INC COM 1,903,300 176,531,000 1.86%
17 INTUITIVE SURGICAL INC 276,800 166,371,000 1.75%
18 EXPRESS SCRIPTS HLDG CO 2,421,000 166,298,000 1.75%
19 VERTEX PHARMACEUT 1,869,400 148,599,000 1.56%
20 ILLUMINA INC 900,000 145,899,000 1.54%
21 TEVA PHARMACEUTICAL INDS LTD 2,696,000 144,263,000 1.52%
22 INTERCEPT PHARMACEUTICAL 1,120,000 143,886,000 1.51%
23 AGILENT TECHNOLOGIES INC 3,495,000 139,276,000 1.47%
24 Wright Medical Group NV 8,345,110 138,529,000 1.46%
25 MAGELLAN HEALTH INC COM NEW 1,909,000 129,678,000 1.36%
26 IRONWOOD PHARMACEUTICALS INC COM CL A 11,550,400 126,361,000 1.33%
27 COOPER COS INC 795,900 122,545,000 1.29%
28 PFIZER INC 4,122,000 122,176,000 1.29%
29 NEUROCRINE BIOSCIE COM USD0.001 2,653,874 104,961,000 1.10%
30 UNITEDHEALTH GROUP INC 812,000 104,667,000 1.10%
31 RELYPSA INC 7,400,000 100,270,000 1.06%
32 ALLERGAN PLC 104,200 95,774,000 1.01%
33 ACHILLION PHARMACEUTICALS INC COM 11,519,700 88,932,000 0.94%
34 OPHTHOTECH CORP COM 2,094,500 88,535,000 0.93%
35 BIOMARIN 1,023,200 84,394,000 0.89%
36 TESARO INC 1,912,000 84,185,000 0.89%
37 PUMA BIOTECHNOLOGY 2,753,425 80,868,000 0.85%
38 MALLINCKRODT PUB LTD CO SHS 1,309,000 80,216,000 0.84%
39 CORVUS PHARMACEUTICALS INC COM 5,258,450 76,248,000 0.80%
40 INSYS THERAPEUTICS INC NEW COM NEW 4,557,740 72,878,000 0.77%
41 NUVASIVE INC COM 1,487,000 72,343,000 0.76%
42 HUMANA 339,700 62,148,000 0.65%
43 LOXO ONCOLOGY INC COM 2,175,857 59,488,000 0.63%
44 JOHNSON & JOHNSON 531,800 57,541,000 0.61%
45 IMMUNOGEN INCORPORATED 6,095,647 51,935,000 0.55%
46 SHIRE PLC 300,371 51,634,000 0.54%
47 SPDR SER TR 981,200 50,689,000 0.53%
48 MEDTRONIC PLC 666,299 49,972,000 0.53%
49 GLAUKOS CORP 2,897,938 48,859,000 0.51%
50 CIGNA CORPORATION 335,500 46,044,000 0.48%
Page 1 of 3

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-003439, filed 2016.05.16).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.